New Clinical and Translational Science Project

Request for Applications

The CTSI offers a broad range of expert support at no cost to researchers through the expertise and resources by cores that include biostatistics, epidemiology, and research design (BERD); recruitment to clinical trials; clinical research facilitation; regulatory support; expertise in biomedical informatics; an extensive portfolio of educational and training workshops and seminars; and a mentored career development program for early-stage investigators.

This RFA is a call for translational science projects. The downloadable full RFA details the process and includes examples for clarification. The CTSI will be applying for a new Clinical and Translational Science Project initiative as part of our CTSA grant. One or two projects will be included as part of our funding proposal to be submitted in December 2023.

An information session was held via Zoom on January 23. Watch a recording of the session here and download the session slides here.

Please contact Timothy Murphy, MD (, to discuss. The CTSI will work with you in designing and planning your project.


Eligibility criteria:

  • Full-time faculty member at UB and eligible to serve as a PI of an NIH grant
  • Have the expertise and research experience to enable the proposed work


Projects related to health disparities and multi-PI projects led by investigators from two different disciplines are strongly encouraged.

Submission of Letter of Intent (2 page limit) due February 21, 2023.

Please provide:

  • Title of proposed research project
  • List of Key Personnel
  • Overview, including the translational science question
  • Specific Aims
  • Approach
  • Roadblock to be addressed
  • Generalizable innovations/insights
  • Impact statement and Dissemination plan
  • NIH Biosketch for each investigator

Combine all documents in one PDF and submit to:


Review criteria:

  • Does the project address a critical problem or barrier in the field of clinical and translational science?
  • Does the project team have experience in clinical and translational research and the expertise to successfully perform the proposed project?
  • Are the specific aims of the project clear, well thought out and feasible?
  • Does the project use novel or innovative approaches to challenge or shift current research, clinical practice, or implementation paradigms?
  • Does the project have the potential to provide sustainable, generalizable innovations that increase the efficiency or effectiveness of translation
  • Are there opportunities for collaborations throughout the Buffalo Translational Consortium and/or other CTSA Program hubs? 

The LOIs will be reviewed. Those that are under consideration for moving forward, to be included in the CTSA application, will be contacted for individual development meetings.